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Background: PET and SPECT brain imaging are widely used as diagnostic tools for 
suspected dementia but no studies have directly compared participant views of the two 
procedures. We used a range of methods to explore preferences for PET and SPECT. 
Methods: Patients and controls (and accompanying carers) completed questionnaires 
immediately after undergoing PET and SPECT brain scans. Pulse rate data were collected 
during each scan. Scan attributes were prioritised using a card sorting exercise; carers and 
controls additionally answered willingness to pay questions.  
Results: Few differences were found either between the scans or groups of participants, 
although carers marginally preferred SPECT. Diagnostic accuracy was prioritised over other 
scan characteristics. Mean heart rate during both scans was lower than baseline heart rate 
measured at home (p<.001).  
Conclusion: Most participants viewed PET and SPECT scans as roughly equivalent and did 
not have a preference for either scan. Carer preference for SPECT is likely to reflect their 
desire to be with the patient (routine practice for SPECT but not for PET), suggesting that 
they should be able to accompany vulnerable patients throughout imaging procedures 
wherever possible. Pulse rate data indicated that brain imaging was no more stressful than a 
home visit from a researcher. The data do not support the anecdotal view that PET is a more 
burdensome procedure and the use of PET or SPECT scans in dementia should be based 
on diagnostic accuracy of the technique. 
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Distinguishing dementia subtypes facilitates optimal management and enables the provision 
of appropriate information to patients and carers about likely symptomatology and prognosis. 
Clinical trials also rely on accurate diagnosis of dementia subtypes. Current guidelines 
recommend blood flow (hexamethylpropyleneamine oxime, HMPAO) Single Photon 
Emission Computed Tomography (SPECT) or functional brain imaging using glucose 
(fludeoxyglucose, FDG) Positron Emission Tomography (PET) to facilitate differential 
diagnosis of the cause of the dementia syndrome when diagnosis is in doubt (Gauthier, 
2012; Hort et al., 2010; NICE/SCIE, 2006). There is growing evidence that PET is more 
accurate as a diagnostic tool (Herholz, 2011; Ishii and Minoshima, 2005; O’Brien et al., 
2014). Decisions about the use of PET or SPECT may also be influenced by availability, 
financial cost and perceived acceptability to patients. SPECT has been more readily 
available and significantly cheaper than PET (Colloby and O'Brien, 2004). However, PET is 
now more widely available and the price of FDG, used for PET, has reduced significantly 
over the last ten years (O’Brien et al., 2014). Anecdotally PET is perceived as more 
burdensome for patients than SPECT (NICE/SCIE, 2006) but little is known about the patient 
experience of undergoing imaging or patient preferences (Davison and O'Brien, 2014). 
Although PET and SPECT are both nuclear medicine scans, the procedures are more 
involved for PET than for SPECT. For example, patients have to fast and have their glucose 
checked prior to PET and while carers are able to stay with patients throughout SPECT 
scans, they are usually not allowed in the room during PET scans due to concerns about 
their exposure to the higher level of radiation associated with PET. Patient views on the 
acceptability of SPECT and PET could help inform future decisions regarding the most 
appropriate imaging procedure (Davison and O'Brien, 2013). 
 
As part of a study which investigated the diagnostic utility of PET with SPECT in 
distinguishing between people with neurodegenerative dementia (Alzheimer’s disease (AD) 
and DLB) and normal controls (O’Brien et al., 2014), we collected data on participants’ views 
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of SPECT and PET brain imaging. Our aim was to develop a detailed understanding of 
participant views and experiences of the two scans and to explore whether the anecdotal 





Patients aged over 60 with mild to moderate dementia (MMSE>12) (Folstein et al., 1975) 
who met the criteria for probable AD (McKhann et al., 1984) or probable DLB (McKeith et al., 
2005) were recruited prospectively from clinical services in north east England. We also 
recruited age-matched controls with no signs or symptoms of dementia who had expressed 
a willingness to participate in research studies. All participants underwent detailed 
neuropsychiatric investigation prior to imaging (O’Brien et al., 2014). SPECT and PET scans 
were completed on separate occasions within one month. The order of the scans was 
alternated between consecutive subjects in each group. The views of carers accompanying 
patients to the scans were also sought. 
 
SPECT head scans were undertaken using a Siemens Symbia dual-detector gamma 
camera. Subjects were comfortably seated in a quiet room, with eyes open for a bolus 
intravenous injection of 500 MBq of Tc-99m HMPAO (Ceretec (exametazime)). They then 
either returned to the nuclear medicine waiting room for up to 30 minutes or proceeded 
directly to the camera room. Imaging time was 25 minutes. This process reflected the 
standard practice in a busy clinical department. 
 
PET-CT scans were undertaken using a Siemens Biograph Truepoint PET-CT. Imaging took 
place approximately 30 minutes after intravenous injection of 250 MBq 18F-FDG 
(fluorodeoxyglucose). Subjects were asked to fast for four hours pre-injection and blood 
glucose was tested. During the injection, subjects were comfortably seated in a quiet room, 
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with eyes open. They then remained alone in an individual cubicle until their scan. Imaging 
took approximately ten minutes. Although the equipment and procedures used were similar 
to those used in clinical settings, the PET scans took place in a university clinical research 
facility, while the SPECT scans were done in a UK NHS hospital department. All scans were 
performed by NHS staff. 
 
Data collection  
An overview of all data collection procedures is provided in Table 1. The development, 
content and administration of each measure are described below. 
 
[Insert Table 1 about here please] 
 
Questionnaires 
While patients have made direct comparisons of different diagnostic procedures in previous 
studies (Liang et al., 2003; Sparrow et al., 2004), people with dementia were unlikely to be 
able to recall details of the imaging procedures after any length of time. To capture 
participants’ experiences and views on the two scans, the questionnaires were therefore 
administered immediately after each scan.  
 
Parallel questionnaires were produced for patients, controls and carers accompanying 
patients to the scan. The content of the questionnaires was informed by:  
 existing literature on patient views of diagnostic procedures (Sparrow et al., 2004; 
Wollman et al., 2004);  
 observation of routine practice in PET and SPECT suites; and  
 semi-structured interviews with five people with dementia referred for SPECT 




Questionnaires for patients and controls were interviewer-administered and took around ten 
minutes to complete. The carer questionnaire was usually self-completed. Three open 
questions were included on each questionnaire to elicit views on the best and worst things 
about the scan and to identify any suggested improvements. Three further questions were 
added after use with the first five participants and carers recruited to the main study.  
 
Prioritising task 
We used a simplified version of Q methodology (Baker et al., 2006) to explore the relative 
priority given to attributes of the scan identified as potentially important in the development 
work: 
 Being able to get comfortable in the scanner 
 Length of time for the injection and scan 
 Dose of radiation given 
 Accuracy of the scan 
 How far you have to travel for the scan 
 How confined you feel in the scanner 
 Whether my relative can stay in the room 
 Helpful staff 
 Noise of the scanner 
A further item – having to fast before the scan - was added after the first five participants and 
carers recruited to the main study. Each item was printed on a card and respondents were 
asked to sort the cards according to importance. Additional blank cards were available so 
that respondents could add other factors if needed. Since the prioritising task did not require 





Willingness to pay questionnaire 
The willingness to pay (WTP) questions were completed during the final home visit. We 
used an ‘incremental approach’ (Donaldson and Shackley, 1997) whereby participants were 
asked which scan they preferred (PET or SPECT) and the maximum amount they would be 
willing to pay for their preferred option. We presented cards with amounts ranging from £1 to 
£5000 in random order and asked respondents to sort the cards into three piles: definitely 
willing to pay that amount; definitely not willing to pay; or unsure. Any cards in the unsure 
pile were then reviewed to identify the maximum amount the respondent was willing to pay 
for the preferred scan. Due to concerns over the ability of people with dementia to remember 
and compare both scans, ethical concerns over potential confusion over whether they would 
be required to pay for the procedures and desire to minimise respondent burden, the WTP 
questions were not administered to patients.  
 
Physiological measurement 
Information on average heart rate was collected as an indicator of stress (Sparrow et al., 
2004) using a fingertip pulse oximeter (Pulmolink CMS 50E-W). Normal heart rate was 
ascertained by measurements taken for five minutes during the initial home visit. Further 




The study was sponsored by Northumberland, Tyne and Wear NHS Foundation Trust. 
Ethical approval was given by Newcastle and North Tyneside 1 Research Ethics Committee 
(reference 09/H090688).  
 
Statistical analysis 
All questionnaire items were coded so that higher scores indicate more positive views. To 
test for differences in views of PET and SPECT scans, questions were compared within 
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respondent type (patients, controls, carers) using the Wilcoxon Signed-Ranks test for 
questions with scaled response categories and the McNemar test for those with 
dichotomous responses. Views of patients and controls on each type of scan were 
compared using a Mann Whitney test for two independent samples. Responses to the open 
questions were recoded as a series of binary variables and compared across all three 
groups of respondents (Kruskal Wallis test for independent samples).  
 
The priority given to each attribute of the scan ranked in the prioritising task was recoded as 
important (ranked most, second most or third most important), unimportant (ranked as least, 
second least or third least important) or as neither important nor unimportant (all items not 
ranked at either extreme). The priorities of patients, controls and carers were compared 
using the Kruskal Wallis test for independent samples. The WTP data were subject to simple 
descriptive analyses and a Mann Whitney U test to compare the amounts respondents were 
willing to pay for their preferred scan.  
 
Since the PET scans were considerably shorter than SPECT scans (approximately ten vs 25 
minutes) we divided the pulse rate data into eight minute segments to directly compare the 
two scans. (This allowed some time for the pulse rate to stabilise at the start of the 
recording). The first eight minute segment was subdivided into two four minute segments to 
allow us to compare pulse rate during these two segments of both scans; the second and 
third 8 minute segments of pulse data for the SPECT scan were used to explore whether 
participants found the scan more or less stressful as duration of scan increased (comparable 




We recruited 102 subjects, of whom 3 withdrew before completing both scans, and 1 was 
excluded due to scanner technical problems. A total of 38 people with AD, 30 with DLB and 
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30 controls were successfully scanned with both PET and SPECT. Questionnaire data were 
not completed by the first eight people recruited to the study (5 controls, 3 patients) since the 
questionnaires were awaiting ethical approval. The questionnaires for one further patient 
were unavailable. Patients and controls were matched on age (mean age 76, standard 
deviation (SD) 6.4 years) and gender (69% male). As expected, patients had significantly 
lower MMSE scores (mean 21, SD 3.9) than controls (mean 29, SD 1.1, p<0.001, t-test) and 
were also more likely to have previously undergone a SPECT scan (16% patients vs 0% of 
controls, p=0.03, Chi square).  
 
For those patients completing questionnaires, the average duration of dementia was 39.8 
months (range 9-120 SD 22 months); 53 % had a diagnosis of AD and 47%  DLB. A carer 
accompanied 62 patients to both scans and 60 of these completed post-scan 
questionnaires. One carer was unavailable at the final home visit and therefore the analysis 
of the prioritising task and WTP questionnaire is based on 59 carers.  
 
Preference questionnaires 
Comparison of responses for PET and SPECT indicated minimal differences (Figure 1).  
 
 
[Insert Figure 1 about here please] 
 
Carers’ views were broadly similar to those of patients and controls. For patients and carers 
the key difference between the scans was, as expected, whether the carer was in the room 
during the scan (PET: 0% for patients and carers; SPECT: 70.3% patients and 69.5% 
carers;; p<0.001 for both patients and carers, McNemar test). The subjective feeling of 
isolation during the scan did not, however, differ for patients although carers were more 
likely to report feeling cut off from their relative during the PET scan (mean (SD) 3.5 (1.2)) 
than SPECT (mean (SD) 4.2 (0.9), p<0.001, Wilcoxon signed ranks test). Carers were also 
 11 
 
more likely to report that their relative was anxious prior to the PET scan (mean (SD) 3.1 
(1.2)) than SPECT (mean (SD) 3.3 (1.3), p=0.03, Wilcoxon signed ranks test). For controls, 
the only significant difference between the two scans related to whether they found the 
temperature comfortable (73.7% for PET vs 94.7% for SPECT, p=0.02, Wilcoxon signed 
ranks test).  
 
Some significant differences between patients and controls were observed, with controls 
generally feeling more positive about the scans than patients. In relation to both PET and 
SPECT scans controls felt more positive prior to the scan (mean (SD) PET: 3.9 (0.3) for 
controls and 3.2 (0.8) for patients, p<0.001; SPECT: 3.8 (0.4) for controls and 3.3 (0.9) for 
patients, p=0.003, Mann Whitney U test); they rated the explanation provided by staff more 
highly (mean (SD) PET: 4.0 (0.2) for controls and 3.8 (0.5) for patients, p=0.04; SPECT: 4.0 
(0.2) for controls and 3.4 (1.2) for patients, p=0.04, Mann Whitney U test); and they gave a 
higher overall rating for the scan on a seven-point scale (mean (SD) PET: 5.5 (0.6) for 
controls and 5.0 (0.7) for patients, p<0.001; SPECT: 5.5 (0.5) for controls and 5.0 (0.8) for 
patients, p=0.003, Mann Whitney U test).  In addition, controls rated the SPECT scan as 
more comfortable than patients (mean (SD) 3.6 (0.7) for controls and 3.0 (1.1) for patients, 
p=0.02, Mann Whitney U test). 
  
Since patients, controls and carers made similar comments to the open questions; the 
results for all respondents have been combined. The chance to help with research and the 
interaction with staff were identified as the most positive aspects of both scans. The most 
negative aspect of their experience related to the scan itself (e.g. feeling cold or 
uncomfortable). While the majority of respondents did not suggest any improvements to the 
procedures (79% for SPECT and 82% for PET), there were a number of potentially useful 
suggestions. Most of these related to improving comfort during the scan (41% of 
suggestions relating to PET and 52% of those relating to SPECT). These included: 
increasing the width of the scan bed (or providing arm rests); providing a pillow for under the 
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knees; and providing a blanket (or increasing the ambient temperature). Other suggestions 
were to reduce waiting time; provide more information on what to expect and to provide 
more feedback during the scan (e.g. how long was left). 
 
Prioritising task 
None of the attributes was consistently viewed positively or negatively by all respondents 
(Figure 2). While patients and carers valued the presence of a companion during the scan 
this was not important for controls (p<0.001, Kruskal Wallis). Controls rated the noise of the 
scanner as more important and patients gave a lower rating to feeling confined in the 
scanner (both p<0.05, Kruskal Wallis) (Figure 2). 
 
[Insert Figure 2 about here please] 
 
Willingness to pay 
Controls did not have a significant scan preference; carers had a marginal preference for 
SPECT over PET (one sample Wilcoxon signed ranks test, p=0.05). Nearly three quarters of 
all respondents with a preference were willing to pay for the preferred scan (independent of 
the scan preferred). Although the amounts respondents were willing to pay for SPECT 
(mean £1632, SD 1858, median £1000) were higher than for PET (mean £1074, SD 2197, 
median £100) this was not significantly different (Mann Whitney U test). In the hypothetical 
situation that the non-preferred scan proved more accurate, all respondents who had initially 
expressed a preference stated that they would prefer the more accurate scan. Of those 
without an initial preference, the majority (93%) would prefer the more accurate scan.  
 
Physiological measures 
There were some technical difficulties in obtaining pulse rate data; the number of cases 
used at each data point for analysis ranged from 71 (48 patients and 23 controls) to 92 (66 
patients and 26 controls). Since there were no significant differences in mean pulse rate 
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between patients and controls at any data point; data from both groups were combined. 
While mean pulse rate did not change between the home visit (HV) and pre-SPECT data 
points, it decreased significantly (but numerically very slightly) when attending for a PET 
scan (from 67.9 (SD 11.3) to 65.6 (SD 11.5), p<0.05, analysis of variance, Figure 3). For 
both types of scan, pulse rate was significantly lower during the scan than on arrival at the 
clinic (both p<0.001, analysis of variance). Compared to beginning of the scan, pulse rate 
significantly lowered towards the end of the PET scan (p<0.001, analysis of variance); in 
contrast, while pulse rate declined gradually throughout the longer SPECT scan the 
difference did not reach statistical significance.  
 
 [Insert Figure 3 about here please] 
 
Discussion 
This study is the first to compare consumer views of PET and SPECT brain imaging for 
diagnosis of dementia. Our findings suggest that the two types of scans were equally 
acceptable to the majority of people with dementia, their carers and to healthy controls. 
There was also evidence that, even where a preference for one scan was expressed, 
diagnostic accuracy overruled any initial preferences suggesting that this was more 
important than other scan characteristics. Economic theory would use the willingness to pay 
amounts as representative of the strength of preference for each scan. The mean amounts 
respondents were willing to pay were not significantly different between PET and SPECT 
again confirming the lack of a strong preference for either scan. Pulse rate data indicated 
that for most participants, the experience of brain imaging was no more stressful than 
completing questionnaires in their own homes. Although some statistically significant 
differences were observed in heart rate, the effect size was very small and not of clinical 
significance. A previous study similarly found that SPECT and MRI imaging procedures had 




It is of interest that participants’ views and preferences seemed unaffected by the duration of 
the scan (SPECT scans took over twice as long as PET scans) or the physical surroundings. 
While SPECT scans took place in a busy hospital department, PET scans took place at a 
University Research Facility in a quiet clinic with typically only one patient attending at a 
time. Responses showed that some participants preferred the busier clinic since they 
enjoyed chatting with other patients whilst waiting for their scan. The importance of individual 
preferences was also evident on questions relating to comfort during the scan. Up to one 
fifth of participants felt cold during scans suggesting that either the ambient temperature 
needs to be increased or blankets need to be provided. Some participants would have 
welcomed pillows or eye masks. While blankets and pillows were available, these were not 
routinely offered to patients. The results highlight the need for a person-centred approach, 
addressing the needs of individual patients. Staff may also benefit from training in 
communicating with people with dementia to ensure that patients have a better 
understanding of the procedures they are to undergo.  
 
A key difference between PET and SPECT scans was that carers were able to remain with 
the patient throughout SPECT scans, but not during the uptake and scanning phase of PET 
in order to keep radiation exposure as low as reasonably achievable (ALARA principle). 
Previous research has shown that a high proportion of older patients, particularly those with 
dementia, are accompanied to medical consultations (Ishikawa et al., 2006). Having a 
companion present can reassure both the patient and their carer and may enhance the 
quality and even feasibility of a successful scan. Over one third of patients and carers felt 
having a companion during the scan was important. Guidance allows for ‘comforters and 
carers’ to legally exceed the normal radiation dose limits, providing that they do so knowingly 
and willingly (i.e. doses have been estimated and explained to them)(Singleton et al., 2003). 
Available evidence indicates that the dose for companions waiting with a patient in the FDG 
uptake phase is surprisingly low (Singleton et al., 2003), suggesting scope for increased 
flexibility regarding the presence of carers throughout PET scans with vulnerable patient 
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groups, such as people with dementia. Alternative approaches to allowing patients to remain 
in contact with their carer during PET scans, such as intercom systems, could also be 
considered.  
 
Implications for research 
The questionnaires about patient views and experiences of each scan were completed 
immediately after the scan to minimise problems with recall. While some patients with 
dementia were not able to recall all details of the scan, they successfully completed the 
majority of questions, confirming that this approach was acceptable and feasible for people 
with dementia. While only one study using Q methodology with people with Alzheimer’s 
disease has been reported (Forrest, 2000) this approach has some similarities to Talking 
Mats which can facilitate communication with people with dementia (Murphy et al., 2010). 
The majority of people with dementia successfully completed our simplified version of Q 
methodology confirming that this can be a useful approach for exploring the views and 
preferences of people with dementia.  
 
Strengths and limitations of the study 
The use of different approaches to data collection allowed us to explore preferences in detail 
and increases confidence in our findings. Although the questionnaires relating to each scan 
were identical, different members of staff administered the questionnaires after PET and 
SPECT and this could potentially have influenced the results. Participants in the study were 
not attending for routine scans but had volunteered to take part in a research study; their 
views towards the scans may potentially be more positive than those of patients attending 
for diagnostic purposes. The different settings for PET and SPECT scans in the present 
study could have influenced our results (although there was no evidence of a consistent 
preference for either setting). Future studies could explore patient views on PET and SPECT 
scans conducted in more similar environments. There were some problems with obtaining 
readings from the fingertip pulse oximeter. There is, however, no reason to suggest that the 
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participants with missing data differed systematically from those with complete pulse rate 
readings. Although we did not adjust for multiple comparisons this was to ensure that we 
captured any differences between participant views of PET and SPECT and increases our 
confidence in concluding that, from the perspective of participants, there are minimal 
differences between the two imaging procedures. 
 
Conclusion 
The majority of participants viewed the experience of PET and SPECT scans as roughly 
equivalent although carers had a marginal preference for SPECT. Diagnostic accuracy was 
prioritised over other characteristics of scans (e.g. time taken, comfort on the scanner). The 
presence of a companion was important to some people with dementia and carers and may 
explain carers’ preference for SPECT. Pulse rate data indicated that for most participants, 
the experience of brain imaging was no more stressful than completing standardised 
questionnaires in their own homes. Possible ideas for service development include a more 
person-centred approach to improve comfort during scans and a more flexible approach to 
the presence of carers during PET scans. Overall our findings indicate that the decision 
whether to use PET or SPECT scans in dementia should be based on diagnostic accuracy 
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Table 1 Overview of study procedures 
DATA TYPE PARTICIPANTS WHEN COLLECTED 
Questionnaire  Patients, controls & carers Immediately after each scan 
Prioritising task  Patients, controls & carers Final home visit 
Willingness to pay Controls & carers Final home visit 
Pulse rate  Patients & controls 5 minutes at initial home visit 
5 minutes on arrival for each scan 






























* – Scoring of item reversed  
 
 
How are you feeling about having the 
scan today?  
 
 
How satisfied were you with the length of 
time you had to wait between your 
appointment time and the injection? 
 
How satisfied were you with the length of 
time you had to wait between the injection 
and the scan? 
 
 
How comfortable were you with the 
distance between you and the scanner? 
 
 
How quickly did the time pass while you 
were in the scanner? 
 
 
How physically comfortable were you 
when lying on the scanner? 
 
 





How isolated or cut-off from people did 




Did staff put you at your ease? 
 
 
Did staff explain what was going to 
happen? 
 
Given the time and effort involved in 
coming for the scan today, how 
worthwhile is this type of scan if it makes 
a correct diagnosis for eight out of ten 
patients? 
 




Figure 2 Percentage of respondents rating scan attributes as important 
 


















Figure 3 Mean heart rate readings at different time points for PET and SPECT scans   
  
PET scans were completed within ten minutes therefore there are no data for later 
timepoints. 
 
 
 
